We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$112M
AUM Growth
Cap. Flow
+$113M
Cap. Flow %
100.69%
Top 10 Hldgs %
24.48%
Holding
83
New
83
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.12M
2
XOM icon
ExxonMobil
XOM
+$3.07M
3
KO icon
Coca-Cola
KO
+$2.91M
4
PEP icon
PepsiCo
PEP
+$2.9M
5
MSFT icon
Microsoft
MSFT
+$2.83M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 13.64%
2 Technology 12.83%
3 Consumer Staples 12.1%
4 Healthcare 10.82%
5 Financials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$465B
$957K 0.85%
+23,159
New +$1.01M
JNJ icon
52
Johnson & Johnson
JNJ
$643B
$913K 0.81%
+10,640
New +$903K
PG icon
53
Procter & Gamble
PG
$347B
$839K 0.75%
+10,899
New +$855K
ABT icon
54
Abbott
ABT
$187B
$808K 0.72%
+23,165
New +$850K
VEU icon
55
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$779K 0.69%
+17,635
New +$825K
AMJ
56
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$776K 0.69%
+16,640
New +$771K
HD icon
57
Home Depot
HD
$343B
$771K 0.69%
+9,960
New +$748K
AMLP icon
58
Alerian MLP ETF
AMLP
$12.9B
$757K 0.67%
+8,482
New +$748K
AOR icon
59
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.65B
$713K 0.63%
+20,122
New +$724K
IBM icon
60
IBM
IBM
$214B
$689K 0.61%
+3,771
New +$734K
BBH icon
61
VanEck Biotech ETF
BBH
$409M
$632K 0.56%
+9,225
New +$642K
DUK icon
62
Duke Energy
DUK
$101B
$556K 0.49%
+8,247
New +$583K
BXP icon
63
Boston Properties
BXP
$11.2B
$515K 0.46%
+4,885
New +$530K
PFE icon
64
Pfizer
PFE
$144B
$489K 0.43%
+18,426
New +$509K
DIS icon
65
Walt Disney
DIS
$172B
$427K 0.38%
+6,770
New +$428K
JPM icon
66
JPMorgan Chase
JPM
$950B
$415K 0.37%
+7,866
New +$400K
KMB icon
67
Kimberly-Clark
KMB
$37.5B
$378K 0.34%
+4,068
New +$392K
LLY icon
68
Eli Lilly
LLY
$1.09T
$367K 0.33%
+7,485
New +$407K
SYY icon
69
Sysco
SYY
$40.7B
$357K 0.32%
+10,465
New +$360K
MRK icon
70
Merck
MRK
$326B
$341K 0.3%
+7,695
New +$344K
SYK icon
71
Stryker
SYK
$133B
$305K 0.27%
+4,724
New +$314K
YUM icon
72
Yum! Brands
YUM
$41.4B
$299K 0.27%
+6,009
New +$298K
NEE icon
73
NextEra Energy
NEE
$186B
$296K 0.26%
+14,560
New +$289K
CTAS icon
74
Cintas
CTAS
$86B
$295K 0.26%
+25,916
New +$292K
PAYX icon
75
Paychex
PAYX
$42.3B
$287K 0.26%
+7,875
New +$290K

Similar funds

Boston Research & Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Boston Research & Management, which disclosed 83 positions worth $112M. Its ten largest holdings account for 24% of the portfolio.

Its largest position is iShares Russell 2000 ETF: 32,697 shares worth $3.17M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q2 2013 buy was iShares Russell 2000 ETF: 32,697 shares worth $3.17M.
  • Boston Research & Management's ten largest holdings make up 24% of its $112M portfolio in Q2 2013.
  • Boston Research & Management disclosed 83 positions in Q2 2013, its first 13F filing on record.

Based on Boston Research & Management's 13F filing for Q2 2013, filed 12 Aug 2013.